These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 2892663

  • 1. [Physiopathology and curative treatment of tardive dyskinesia].
    Wolf MA, Gautier J.
    Encephale; 1987; 13(5):301-8. PubMed ID: 2892663
    [Abstract] [Full Text] [Related]

  • 2. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE.
    J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
    [Abstract] [Full Text] [Related]

  • 3. Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study.
    Rondot P, Bathien N.
    Adv Neurol; 1987; 45():361-6. PubMed ID: 2881446
    [No Abstract] [Full Text] [Related]

  • 4. Tardive dyskinesia and essential fatty acids.
    Vaddadi K, Hakansson K, Clifford J, Waddington J.
    Int Rev Psychiatry; 2006 Apr; 18(2):133-43. PubMed ID: 16777667
    [Abstract] [Full Text] [Related]

  • 5. Tardive dyskinesia. Pathophysiological mechanisms and clinical trials.
    Gerlach J.
    Encephale; 1988 Sep; 14 Spec No():227-32. PubMed ID: 2905651
    [Abstract] [Full Text] [Related]

  • 6. Animal models of tardive dyskinesia--a review.
    Kulkarni SK, Naidu PS.
    Indian J Physiol Pharmacol; 2001 Apr; 45(2):148-60. PubMed ID: 11480221
    [Abstract] [Full Text] [Related]

  • 7. [Late dyskinesia: experimental models, paradoxes and deductions].
    Vamvakidès A.
    Agressologie; 1987 Sep; 28(8):827-30. PubMed ID: 2827536
    [No Abstract] [Full Text] [Related]

  • 8. Neuroleptic-induced tardive dyskinesia.
    Jenner P, Marsden CD.
    Acta Psychiatr Belg; 1987 Sep; 87(5):566-98. PubMed ID: 2897761
    [Abstract] [Full Text] [Related]

  • 9. [Therapeutic trial of gamma-vinyl GABA, an inhibitor of GABA transaminase, in tardive dyskinesias induced by neuroleptics].
    Lambert PA, Cantiniaux P, Chabannes JP, Tell GP, Schechter PJ, Koch-Weser J.
    Encephale; 1982 Sep; 8(3):371-6. PubMed ID: 6137357
    [Abstract] [Full Text] [Related]

  • 10. Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid.
    Bishnoi M, Chopra K, Kulkarni SK.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb 15; 32(2):451-61. PubMed ID: 17988775
    [Abstract] [Full Text] [Related]

  • 11. Tardive dyskinesia: a role for the endogenous opioid system.
    Sandyk R.
    Med Hypotheses; 1986 Jan 15; 19(1):71-4. PubMed ID: 2871480
    [Abstract] [Full Text] [Related]

  • 12. Managing tardive dyskinesia.
    Casey DE.
    J Clin Psychiatry; 1978 Oct 15; 39(10):748-53. PubMed ID: 30759
    [Abstract] [Full Text] [Related]

  • 13. Noncatecholaminergic treatments of tardive dyskinesia.
    Alphs L, Davis JM.
    J Clin Psychopharmacol; 1982 Dec 15; 2(6):380-5. PubMed ID: 6129267
    [Abstract] [Full Text] [Related]

  • 14. Dopaminergic and GABAergic aspects of tardive dyskinesia [proceedings].
    Casey DE, Gerlach J, Magelund G, Christensen TR.
    Psychopharmacol Bull; 1981 Jan 15; 17(1):49-50. PubMed ID: 7232658
    [No Abstract] [Full Text] [Related]

  • 15. [Tardive dyskinesias].
    Mignot G.
    Encephale; 1983 Jan 15; 9(2):151-66. PubMed ID: 6139271
    [Abstract] [Full Text] [Related]

  • 16. [Tardive dyskinesias. Epidemiology and physiopathology].
    Gerlach J.
    Ugeskr Laeger; 1987 Jun 15; 149(25):1678-81. PubMed ID: 2885954
    [No Abstract] [Full Text] [Related]

  • 17. Use of dopamine receptor agonists to reduce dopamine receptor number as treatment for tardive dyskinesia.
    Alpert M, Friedhoff AJ, Diamond F.
    Adv Neurol; 1983 Jun 15; 37():253-8. PubMed ID: 6134444
    [No Abstract] [Full Text] [Related]

  • 18. New aspects on the role of dopamine, acetylcholine, and GABA in the development of tardive dyskinesia.
    Scheel-Krüger J, Arnt J.
    Psychopharmacology Suppl; 1985 Jun 15; 2():46-57. PubMed ID: 2987907
    [Abstract] [Full Text] [Related]

  • 19. [Neuroleptic parkinsonism and tardive dyskinesia and methods of pharmacologically correcting these pathologic conditions (review)].
    Arushanian EB.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985 Jun 15; 85(2):269-77. PubMed ID: 2858951
    [No Abstract] [Full Text] [Related]

  • 20. An update on tardive dyskinesia.
    Simpson GM, Pi EH, Sramek JJ.
    Hosp Community Psychiatry; 1986 Apr 15; 37(4):362-9. PubMed ID: 2870977
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.